Australia - angielski - Department of Health (Therapeutic Goods Administration)

mcpherson's consumer products pty ltd - d-alpha-tocopheryl acid succinate, quantity: 82.64 mg; rutoside, quantity: 15 mg; dibasic potassium phosphate, quantity: 50 mg (equivalent: potassium, qty 22.45 mg); citrus bioflavonoids extract, quantity: 50 mg; glutamine, quantity: 50 mg; magnesium amino acid chelate, quantity: 90 mg (equivalent: magnesium, qty 18 mg); thiamine hydrochloride, quantity: 30 mg; lysine hydrochloride, quantity: 50 mg; manganese amino acid chelate, quantity: 20 mg (equivalent: manganese, qty 2 mg); potassium iodide, quantity: 50 microgram (equivalent: iodine, qty 38.2 microgram; equivalent: potassium, qty 11.8 microgram); nicotinic acid, quantity: 5 mg; cyanocobalamin, quantity: 100 microgram; inositol, quantity: 25 mg; pyridoxine hydrochloride, quantity: 50 mg (equivalent: pyridoxine, qty 41.13 mg); colloidal anhydrous silica, quantity: 32.09 mg (equivalent: silicon, qty 15 mg); calcium pantothenate, quantity: 100 mg (equivalent: calcium, qty 8.39 mg; equivalent: pantothenic acid, qty 91.61 mg); calcium ascorbate dihydrate, quantity: 110 mg (equivalent: calcium, qty 10.3 mg; equivalent: ascorbic acid, qty 90.87 mg); selenomethionine, quantity: 124.2 microgram (equivalent: selenium, qty 50 microgram); taurine, quantity: 100 mg; folic acid, quantity: 400 microgram; riboflavine, quantity: 20 mg; biotin, quantity: 100 microgram; nicotinamide, quantity: 100 mg; zinc amino acid chelate, quantity: 75 mg (equivalent: zinc, qty 15 mg); calcium citrate tetrahydrate, quantity: 84 mg (equivalent: calcium, qty 17.72 mg); choline bitartrate, quantity: 25 mg; chromium nicotinate, quantity: 416.7 microgram (equivalent: chromium, qty 50 microgram); molybdenum trioxide, quantity: 50 microgram (equivalent: molybdenum, qty 33.3 microgram); borax, quantity: 4.41 mg (equivalent: boron, qty 500 microgram); cupric sulfate pentahydrate, quantity: 196.5 microgram (equivalent: copper, qty 50 microgram); betacarotene, quantity: 3 mg; lycopene, quantity: 2 mg; colecalciferol, quantity: 0.005 mg; tagetes erecta, quantity: 20 mg (equivalent: lutein esters calculated as lutein (of tagetes erecta), qty 1 mg; equivalent: tagetes erecta, qty 100 mg); phytomenadione, quantity: 0.05 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; calcium hydrogen phosphate dihydrate; carnauba wax; microcrystalline cellulose; magnesium stearate; tartaric acid; povidone; colloidal anhydrous silica; hypromellose; macrogol 400; ethylcellulose; silicon dioxide; purified water; acacia; sodium alginate; pea starch; starch sodium octenyl succinate; maize starch; sodium ascorbate; dl-alpha-tocopherol; liquid glucose; sucrose; hydrolysed gelatin; hydrogenated soya oil - antioxidant/reduce free radicals formed in the body ; maintain/support collagen formation ; maintain/support energy levels ; maintain/support energy production ; maintain/support healthy eyesight/vision ; maintain/support hair health ; maintain/support healthy teeth ; maintain/support bone health ; maintain/support healthy cardiovascular system function ; maintain/support artery health ; maintain/support healthy immune system function ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; support healthy stress response in the body ; maintain/support cognitive function/mental function ; maintain/support brain function ; maintain/support brain health ; maintain/support skin health ; maintain/support skin integrity/structure

Nigeria - angielski - NAFDAC (National Agency for Food and Drugs Administration and Control)

riboflavine 2mg

Australia - angielski - Department of Health (Therapeutic Goods Administration)

blackmores ltd - riboflavine, quantity: 8.5 mg; nicotinamide, quantity: 60 mg; calcium pantothenate, quantity: 21.8 mg (equivalent: pantothenic acid, qty 20 mg); ascorbic acid, quantity: 300 mg; pyridoxine hydrochloride, quantity: 10 mg (equivalent: pyridoxine, qty 8.23 mg); cyanocobalamin, quantity: 10 microgram; folic acid, quantity: 200 microgram; thiamine nitrate, quantity: 7.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; titanium dioxide; sodium starch glycollate; purified talc; lecithin; calcium hydrogen phosphate dihydrate; curcumin; microcrystalline cellulose; glycerol; carnauba wax; hypromellose

Australia - angielski - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - riboflavine, quantity: 15 mg; nicotinamide, quantity: 30 mg; calcium pantothenate, quantity: 8 mg; pyridoxine hydrochloride, quantity: 5 mg (equivalent: pyridoxine, qty 4.114 mg); cyanocobalamin, quantity: 10 microgram; folic acid, quantity: 150 microgram; thiamine nitrate, quantity: 15 mg - tablet, film coated - excipient ingredients: isomalt; crospovidone; sunset yellow fcf aluminium lake; purified talc; calcium lactate pentahydrate; microcrystalline cellulose; magnesium stearate; quinoline yellow aluminium lake; colloidal anhydrous silica; titanium dioxide; macrogol 6000; hypromellose; calcium hydrogen phosphate dihydrate; flavour - maintain/support energy levels ; helps convert (state food) into energy ; maintain/support energy production ; maintain/support general health and wellbeing ; maintain/support heart health ; aid/assist digestion/breakdown of dietary fat ; maintain/support nervous system function

Australia - angielski - Department of Health (Therapeutic Goods Administration)

ozam nutritionals - riboflavine, quantity: 850 microgram; betacarotene, quantity: 3 mg; vaccinium myrtillus; citrus bioflavonoids extract, quantity: 50 mg; daucus carota, quantity: 150 mg - capsule, hard - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; magnesium stearate; maize starch; ascorbyl palmitate; sodium ascorbate; potable water; calcium phosphate; gelatin; dl-alpha-tocopherol; sucrose; lactose monohydrate; purified water; sodium lauryl sulfate - not provided. at overseas importer's discretion compliant with the importing country legal requirements.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - hydrochlorothiazide, quantity: 50 mg; amiloride hydrochloride dihydrate, quantity: 5 mg - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate dihydrate; lactose monohydrate; maize starch; guar gum; sunset yellow fcf; pregelatinised maize starch; magnesium stearate - indicated in the treatment of patients with oedema of cardiac origin; hepatic cirrhosis with ascites; hypertension in whom potassium depletion might be anticipated. moduretic, with its combination of amiloride hcl and hydrochlorothiazide, minimises the possibility of the development of excessive potassium loss in patients during vigorous diuresis for prolonged periods. moduretic, with its built-in potassium sparing agent, is especially indicated in those conditions where the positive effect on potassium balance is particularly important. moduretic may be used alone, or as an adjunct to other antihypertensive drugs. since it enhances the action of these agents, the dosage of these antihypertensive drugs may need to be reduced to avoid the risk of excessive drop in blood pressure.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

symbion pty ltd - inositol, quantity: 40 mg; thiamine nitrate, quantity: 25 mg; folic acid, quantity: 250 microgram; ferrous fumarate, quantity: 8 mg (equivalent: iron, qty 2.6 mg); ascorbic acid, quantity: 100 mg; pyridoxine hydrochloride, quantity: 25 mg (equivalent: pyridoxine, qty 20.5 mg); biotin, quantity: 100 microgram; heavy magnesium oxide, quantity: 75 mg (equivalent: magnesium, qty 45.2 mg); riboflavine, quantity: 25 mg; colecalciferol, quantity: 1.25 microgram; calcium carbonate, quantity: 300 mg (equivalent: cal - tablet, film coated - excipient ingredients: carnauba wax; medium chain triglycerides; silicon dioxide; crospovidone; calcium hydrogen phosphate dihydrate; maltodextrin; acacia; magnesium stearate; maize starch; hypromellose; sucrose; dl-alpha-tocopherol; microcrystalline cellulose; chlorophyllin-copper complex; sodium ascorbate; ascorbyl palmitate; potable water; calcium phosphate; gelatin; titanium dioxide; purified talc; macrogol 3000; polyvinyl alcohol; lecithin - maintain/support hair health ; maintain/support nail health/strength/thickness ; aid/assist/helps connective tissue production/formation ; maintain/support skin health ; maintain/support skin integrity/structure ; maintain/support wound healing ; maintain/support skin repair/healing/regeneration

Australia - angielski - Department of Health (Therapeutic Goods Administration)

blackmores ltd - riboflavine, quantity: 8.5 mg; nicotinamide, quantity: 60 mg; calcium pantothenate, quantity: 21.8 mg (equivalent: pantothenic acid, qty 20 mg); ascorbic acid, quantity: 180 mg; pyridoxine hydrochloride, quantity: 10 mg (equivalent: pyridoxine, qty 8.23 mg); biotin, quantity: 50 microgram; cyanocobalamin, quantity: 10 microgram; folic acid, quantity: 200 microgram; magnesium phosphate pentahydrate, quantity: 847 mg (equivalent: magnesium, qty 175 mg); potassium sulfate, quantity: 167.25 mg (equivalent: potassium, qty 75 mg); thiamine nitrate, quantity: 7.5 mg; zinc sulfate monohydrate, quantity: 41.55 mg (equivalent: zinc, qty 15 mg) - tablet, film coated - excipient ingredients: carnauba wax; microcrystalline cellulose; hypromellose; magnesium stearate; glycerol; sodium starch glycollate; iron oxide black; titanium dioxide; hydrogenated vegetable oil; acacia; iron oxide yellow; iron oxide red; calcium hydrogen phosphate dihydrate

Australia - angielski - Department of Health (Therapeutic Goods Administration)

blackmores ltd - riboflavine, quantity: 8.5 mg; nicotinamide, quantity: 60 mg; calcium pantothenate, quantity: 21.8 mg (equivalent: pantothenic acid, qty 20 mg); ascorbic acid, quantity: 180 mg; pyridoxine hydrochloride, quantity: 8 mg (equivalent: pyridoxine, qty 6.58 mg); biotin, quantity: 50 microgram; cyanocobalamin, quantity: 10 microgram; folic acid, quantity: 200 microgram; dibasic potassium phosphate, quantity: 167 mg (equivalent: potassium, qty 75 mg); magnesium phosphate pentahydrate, quantity: 847 mg (equivalent: magnesium, qty 175 mg); thiamine nitrate, quantity: 6.5 mg; zinc sulfate monohydrate, quantity: 42 mg (equivalent: zinc, qty 15 mg) - tablet, film coated - excipient ingredients: acacia; microcrystalline cellulose; carmellose sodium; magnesium stearate; glycerol; hypromellose; carnauba wax; calcium hydrogen phosphate; colloidal anhydrous silica

Australia - angielski - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - riboflavine sodium phosphate, quantity: 5 mg/ml; nicotinamide, quantity: 50 mg/ml; dexpanthenol, quantity: 25 mg/ml; pyridoxine hydrochloride, quantity: 50 mg/ml; cyanocobalamin, quantity: 250 microgram/ml - injection, solution - excipient ingredients: disodium edetate; water for injections; benzyl alcohol - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. commonly, several b vitamin deficiencies may occur similtaneously. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. note: b-dose plus 2ml injection does not contain thiamine. 5. peripheral neuritis caused by various b group de